MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Systemic Lupus Erythematosus

Latest Research

Latest Advance
Study
  • Condition: Older Patients with Systemic Lupus Erythematosus
  • Journal: Arthritis research & therapy
  • Treatment Used: Hydroxychloroquine
  • Number of Patients: 5
  • Published —
The study researched the safety and effectiveness of stopping Hydroxychloroquine in older patients with systemic lupus erythematosus.
Latest Advance
Study
  • Condition: Systemic Lupus Erythematosus
  • Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
  • Treatment Used: Corticosteroids
  • Number of Patients: 153
  • Published —
The study researched the treatment of arterial hypertension in systemic lupus erythematosus.
Latest Advance
Study
  • Condition: COVID-19
  • Journal: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis
  • Treatment Used: Statins
  • Number of Patients: 1
  • Published —
This review analyzes using statins as an adjunctive treatment in patients with COVID-19.
Latest Advance
Study
  • Condition: Coronavirus Disease 2019 (COVID-19)
  • Journal: Journal of cardiovascular pharmacology and therapeutics
  • Treatment Used: Hydroxychloroquine (HCQ)
  • Number of Patients: 0
  • Published —
This study discussed patients with coronavirus disease 2019 (a serious viral infection affecting the respiratory system; COVID-19) in order to review hydroxychloroquine (HCQ) as a potential treatment.
Latest Advance
Study
  • Condition: Enthesitis and Dactylitis in Moderate to Severe Psoriatic Arthritis
  • Journal: RMD open
  • Treatment Used: Guselkumab
  • Number of Patients: 149
  • Published —
The study researched the safety and effectiveness of guselkumab for enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis.
Latest Advance
Study
  • Condition: Polyarticular Juvenile Idiopathic Arthritis
  • Journal: RMD open
  • Treatment Used: Adalimumab with or without Methotrexate
  • Number of Patients: 171
  • Published —
The study researched the outcomes of adalimumab with or without methotrexate for polyarticular juvenile idiopathic arthritis.
Latest Advance
Study
  • Condition: SARS-CoV-2 infection
  • Journal: Journal of medical virology
  • Treatment Used: Chronic Treatment with Hydroxychloroquine
  • Number of Patients: 26815
  • Published —
This study analyzed data on all cases chronically receiving hydroxychloroquine sulphate (HCQ) for the management of diseases such as systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune disease and detected all laboratory confirmed cases of SARS-CoV-2 infection and all laboratory confirmed negative cases in the Portuguese population.
Latest Advance
Study
  • Condition: Thrombotic Microangiopathy
  • Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
  • Treatment Used: Eculizumab
  • Number of Patients: 1
  • Published —
In this case study, researchers evaluated the use of eculizumab for the treatment of thrombotic microangiopathy due to systemic lupus erythematosus.
Latest Advance
Study
  • Condition: Active Lupus Nephritis
  • Journal: Annals of the rheumatic diseases
  • Treatment Used: Mycophenolate Mofetil Versus Tacrolimus
  • Number of Patients: 150
  • Published —
The purpose of the study was to report the 10-year outcome of lupus nephritis treated with mycophenolate mofetil or tacrolimus induction.
Latest Advance
Study
  • Condition: Autoimmune Disease
  • Journal: Current opinion in ophthalmology
  • Treatment Used: Laser Refractive Surgery (LRS)
  • Number of Patients: 0
  • Published —
This study evaluated the safety and effectiveness of laser refractive surgery (surgical procedure used to fix vision problems; LRS) in patients with autoimmune disease (condition that results when the immune system wrongly attacks its own organs, tissues, glands, or cells).
Latest Advance
Study
  • Condition: Patients with Rheumatic Disease Complicated by COVID-19
  • Journal: The Journal of rheumatology
  • Treatment Used: Hydroxychloroquine
  • Number of Patients: 0
  • Published —
This study characterized hydroxychloroquine exposure in patients with rheumatic disease receiving long-term hydroxychloroquine compared to target concentrations with reported antiviral activity against the 2019 coronavirus SARS-CoV-2.
Latest Advance
Study
  • Condition: COVID-19
  • Journal: Postgraduate medical journal
  • Treatment Used: Hydroxychloroquine and chloroquine
  • Number of Patients: 0
  • Published —
The study researched the use of Hydroxychloroquine and chloroquine for treating COVID-19.
Showing 1–12 of 112 Latest Research
Next